Delivery Order SPE2DB20D2104-SPE2DB23FV14U
Award Date
8/31/23
Potential Completion Date
9/1/23
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract, which runs through November 2026, provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $15,727.27 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the supply of XELJANZ XR 11 MG TABLET, a pharmaceutical product, to support military healthcare programs. The IDC with the DLA is a single-award contract worth up to $999,999,999.00 that runs through November 2026. This vehicle enables...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award has a ceiling value of $4,281.32 and an ultimate completion date of December 28, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract covers the delivery of various medications, including XELJANZ XR 11 MG TABLET, as well as other pharmaceutical products,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The DO, valued at $3,437.93, is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of February 13, 2024. This award is part of Amerisourcebergen's broader pharmaceutical and medical supply contracts with the federal...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $10,328.94 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $42,998.12 for the pharmaceutical product Xeljanz XR 11 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award, valued at $12,169.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $31,560.49 Firm Fixed Price Delivery Order for medical supplies, specifically the pharmaceutical product XELJANZ XR 11 MG TABLET UU 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 4, 2023. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within military...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The $13,004.76 firm fixed-price delivery order, awarded on May 3, 2024, has an ultimate completion date of May 6, 2024. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,650.81 firm fixed-price delivery order is for the supply of the pharmaceutical drug Xeljanz XR 11 mg tablets. The award has an ultimate completion date of January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...